{
  "path": "/aloha-io/title-19/chapter-329e/section-329e-1/",
  "title": "Definitions",
  "type": "hrs_section",
  "structure": {
    "volume": "6",
    "chapter": "329E",
    "section": "329E-1"
  },
  
  
  "next": "https://sammade.github.io/aloha-io/title-19/chapter-329e/section-329e-2/",
  
  "context": "[ยง329E-1] Definitions. The following definitions apply throughout this chapter: &amp;ldquo;Harm reduction organization&amp;rdquo; means an organization that provides services, including medical care, counseling, homeless services, or addiction treatment, to individuals at risk of experiencing an opioid-related drug overdose event or to the friends and family members of an at-risk individual. &amp;ldquo;Health care professional&amp;rdquo; means a physician licensed under chapter 453, physician assistant under the authority and supervision of a physician, or advanced practice registered nurse with prescriptive authority licensed under chapter 457. &amp;ldquo;Opioid antagonist&amp;rdquo; means any drug that binds to opioid receptors and blocks or disinhibits the effects of opioids acting on those receptors, and that is approved by the United States Food and Drug Administration for treating opioid-related drug overdose. &amp;ldquo;Opioid-related drug overdose&amp;rdquo; means a condition including but not limited to extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death resulting from the consumption or use of an opioid, or another substance with which an opioid was combined, or a condition that a layperson would reasonably believe to be an opioid-related drug overdose that requires medical assistance. &amp;ldquo;Pharmacist&amp;rdquo; means a registered pharmacist as defined in chapter 461. &amp;ldquo;Standing order&amp;rdquo; means a prescription order for an opioid antagonist issued by a health care professional who is otherwise authorized to prescribe an opioid antagonist that is not specific to and does not identify a particular patient and which may be applicable to more than one patient. [L 2016, c 68, pt of ยง2] "
}